Evolent Bets on AI-Led Operations as It Raises 2026 Revenue Outlook

Evolent Health raised its full-year 2026 revenue guidance after reporting strong second-quarter results, with executives crediting an emerging AI-led operating model for improving operational efficiency while supporting clinical outcomes.

The healthcare services company reported revenue of $652.5 million for the quarter ended June 30, up from $444.3 million a year earlier. Net loss attributable to common shareholders narrowed to $28.4 million from $51.1 million in the prior-year period, while adjusted EBITDA was $28.1 million. The company also increased its 2026 revenue outlook to between $2.6 billion and $2.7 billion and tightened its adjusted EBITDA guidance to $120 million to $135 million, according to its second-quarter earnings release.

"We are confident in our emerging AI-led operational model that we believe allows us to deliver excellent client and clinical outcomes, while being highly disciplined with our cost structure," Co-Founder and CEO Seth Blackley said in the release.

The results come as healthcare organizations continue to expand AI beyond pilot projects into core operations, a trend reflected in HCA Healthcare's operational AI deployments and other enterprise healthcare initiatives.